Migraines affect millions of people every year and often become recurring headaches that can cause severe pain, usually to one side of the head. These painful headaches can be debilitating without treatment and can sometimes continue for a person’s entire life.
Participants of this study will be placed in one of two groups and may receive an investigational drug or a placebo with no active drug.
To qualify for the study, you must be:
- English speaking males and females ages 19 or older (no upper age limit)
- Younger than 50 at age of onset
- Have a migraine headache frequency between 2 and 8 attacks per month in each of the 3 months prior to screening
- Other criteria may apply*
*There are multiple studies available to participate in and each may require different criteria to be approved as a participant.